Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management

Título

Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management

Autor

Jacob A. Lebin, Kathy T. LeSaint

Descripción

As of April 21, 2020, more than 2.5 million cases of coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, have been reported in 210 countries and territories, with the death toll at 171,810. Both chloroquine and hydroxychloroquine have gained considerable media attention as possible therapies, resulting in a significant surge in demand. In overdose, both medications can cause severe, potentially life-threatening effects. Here, we present a brief overview of the pharmacology of chloroquine and hydroxychloroquine, manifestations of toxicity, and treatment considerations.

Fecha

2020

Identificador

10.5811/westjem.2020.5.47810

Fuente

Western Journal of Emergency Medicine

Editor

eScholarship Publishing, University of California

Cobertura

Medicine, Medical emergencies. Critical care. Intensive care. First aid

Archivos

https://socictopen.socict.org/files/to_import/pdfs/a71510c786fda7690787d6919016b99f.pdf

Colección

Citación

Jacob A. Lebin, Kathy T. LeSaint, “Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management,” SOCICT Open, consulta 18 de abril de 2026, https://socictopen.socict.org/items/show/4237.

Formatos de Salida

Position: 14066 (21 views)